Overview
Updated 14 Jul 2026
Ayalew Tefferi, M.D., is Professor of Medicine (Hematology), Consultant in Hematology at Mayo Clinic, Rochester, Minnesota (Mayo Clinic College of Medicine and Science, Division of Hematology, Department of Medicine). The public record shows 2,093 publications with 104,476 citations (h-index 154), centered on Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments. It also documents an investigator role on 7 registered clinical trials, 1 NIH-funded awards (1993–1999).
- Most recent indexed publication: 2026 · American journal of hematology
- Top research focus: Myeloproliferative Neoplasms: Diagnosis and Treatment
- 7 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 239 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 1,018.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)
Sponsor: Sierra Oncology LLC - a GSK company
InvestigatorPhase 2CompletedNCT01236638 - Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)
Sponsor: Sierra Oncology LLC - a GSK company
InvestigatorPhase 1/PHASE2CompletedNCT00935987 - A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis
Sponsor: Bristol-Myers Squibb
InvestigatorPhase 1/PHASE2CompletedNCT00724334
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
NIH funding
Updated 14 Jul 2026
1 NIH research award on record, funded 1993–1999 per NIH RePORTER. The latest:
- ANTITHYMOCYTE GLOBULIN TREATMENT FOR MYELODYSPLASTIC SYNDROMES
Mayo Clinic Coll of Medicine, Rochester
FY1999M01RR000585 - PHASE I STUDY OF COMBINED CHEMOTHERAPY CONSISTING OF 2-CHLORODEOXYADENOSINE
Mayo Clinic Coll of Medicine, Rochester
FY1994M01RR000585 - PHASE I STUDY OF COMBINED CHEMOTHERAPY CONSISTING OF 2-CHLORODEOXYADENOSINE
Mayo Clinic Coll of Medicine, Rochester
FY1993M01RR000585
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Intensive Induction in AML in the Era of Venetoclax: A Standing Count for "7 + 3"?
American journal of hematology
2026 - Cancer history and second cancer risk in polycythemia vera and essential thrombocythemia.
Blood cancer journal
2026 - Autoimmune and Inflammatory Diseases in Polycythemia Vera and Essential Thrombocythemia: Impact on Disease Outcomes and Comorbidities.
American journal of hematology
2026 - Clinical Experience With Venetoclax-Based Combinations for Relapsed/Refractory or MRD-Positive NPM1-Mutated Acute Myeloid Leukemia.
American journal of hematology
2026
Most-cited worksby citation count (OpenAlex)
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu ↗
- Board Certified
American Board of Internal Medicine - Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com ↗ - Board Certified
American Board of Internal Medicine - Hematology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com ↗
Editorial & leadership rolesjournal and society appointments
- Editor-in-Chief
Blood Cancer Journal (Nature Portfolio), alongside co-Editor-in-Chief Vincent Rajkumar
- Associate/Section Editor
American Journal of Hematology, Leukemia, European Journal of Hematology, Hematological Oncology, and Mayo Clinic Proceedings
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mayo.edu ↗
Awards & honorshonors on the public record
- 2016 Henry M. Stratton Medal for Clinical/Translational Science
American Society of Hematology (ASH), awarded for seminal contributions to clinical/translational hematology research
2016verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hematology.org ↗ - 2008 Emil J. Freireich Medal
University of Texas MD Anderson Cancer Center (highest award for achievement in cancer management) …
2008provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →emedevents.com ↗
Secondary affiliationsappointments beyond the home institution
- Listed specialist/contributor
Aplastic Anemia and MDS International Foundation (AAMDSIF) physician directory
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aamds.org ↗
Media & interviewspress, podcasts and appearances
- "Ayalew Tefferi, MD, on Career Development as a Clinician-Investigator"
Blood Cancers Today podcast
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bloodcancerstoday.com ↗ - "Ayalew Tefferi, MD, on Risk Stratification, Treatment Considerations for Myelofibrosis"
Blood Cancers Today podcast
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bloodcancerstoday.com ↗ - Episode 45
"Updates in Primary Myelofibrosis with Dr. Ayalew Tefferi", Blood Cancer Talks podcast (Spotify)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →open.spotify.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Facebook
facebook.com/ayalew.tefferi
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗
Mentions by otherswhere others cite or feature them
- Doximity
doximity.com/pub/ayalew-tefferi-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/posts/jamanetwork_author-ayalew-tefferi-of-the-mayo-clinic-activity-7289960451625435136-oYgz
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
bloodcancerstoday.com/podcast/ayalew-tefferi-md-on-risk-stratification-treatment-considerations-for-myelofibrosis
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bloodcancerstoday.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Angela Dispenzieri, MD
Mayo Clinic
- 2,490
- publications
- 146
- h-index
- 13
- trials
Shaji Kumar, MD
Mayo Clinic
- 2,207
- publications
- 137
- h-index
- 39
- trials
Morie Gertz, MD
Mayo Clinic
- 1,944
- publications
- 140
- h-index
- 7
- trials
Keith Josephs, MD
Mayo Clinic
- 952
- publications
- 119
- h-index
- 3
- trials